Crawford Investment Counsel’s Amgen AMGN Stock Holding History

Crawford Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.74M	Sell	7,777 -16	-0.2%	-$5.7K	0.05%	178
2025 Q4	$2.55M	Sell	7,793 -25	-0.3%	-$7.93K	0.04%	185
2025 Q3	$2.21M	Sell	7,818 -6	-0.1%	-$1.74K	0.04%	183
2025 Q2	$2.18M	Buy	7,824 +104	+1%	+$29.5K	0.04%	179
2025 Q1	$2.41M	Buy	7,720 +18	+0.2%	+$5.32K	0.04%	178
2024 Q4	$2.01M	Sell	7,702 -3	-0%	-$890	0.04%	184
2024 Q3	$2.48M	Buy	7,705 +100	+1%	+$32.7K	0.04%	176
2024 Q2	$2.38M	Sell	7,605 -219	-3%	-$64.3K	0.05%	168
2024 Q1	$2.22M	Buy	7,824 +215	+3%	+$62.9K	0.04%	166
2023 Q4	$2.19M	Buy	7,609 +15	+0.2%	+$4.09K	0.04%	159
2023 Q3	$2.04M	Hold	7,594	–	–	0.04%	165
2023 Q2	$1.69M	Hold	7,594	–	–	0.03%	169
2023 Q1	$1.84M	Sell	7,594 -10	-0.1%	-$2.46K	0.04%	163
2022 Q4	$2M	Buy	7,604 +281	+4%	+$75.3K	0.04%	163
2022 Q3	$1.65M	Sell	7,323 -39	-0.5%	-$9.45K	0.04%	169
2022 Q2	$1.79M	Sell	7,362 -108	-1%	-$26.5K	0.04%	168
2022 Q1	$1.81M	Buy	7,470 +205	+3%	+$47.1K	0.04%	185
2021 Q4	$1.63M	Sell	7,265 -22	-0.3%	-$4.64K	0.03%	186
2021 Q3	$1.55M	Buy	7,287 +22	+0.3%	+$5.06K	0.03%	179
2021 Q2	$1.77M	Hold	7,265	–	–	0.04%	177
2021 Q1	$1.81M	Hold	7,265	–	–	0.04%	168
2020 Q4	$1.67M	Buy	7,265 +96	+1%	+$22.1K	0.04%	163
2020 Q3	$1.82M	Buy	7,169 +36	+0.5%	+$8.92K	0.05%	158
2020 Q2	$1.68M	Sell	7,133 -117	-2%	-$26.7K	0.05%	153
2020 Q1	$1.47M	Hold	7,250	–	–	0.05%	154
2019 Q4	$1.75M	Hold	7,250	–	–	0.05%	161
2019 Q3	$1.4M	Buy	7,250 +48	+0.7%	+$9.21K	0.04%	167
2019 Q2	$1.33M	Sell	7,202 -21	-0.3%	-$3.76K	0.04%	165
2019 Q1	$1.37M	Hold	7,223	–	–	0.04%	160
2018 Q4	$1.41M	Hold	7,223	–	–	0.05%	150
2018 Q3	$1.5M	Sell	7,223 -260	-3%	-$51.2K	0.05%	151
2018 Q2	$1.38M	Buy	7,483 +384	+5%	+$67.9K	0.04%	150
2018 Q1	$1.21M	Buy	7,099 +98	+1%	+$18K	0.04%	156
2017 Q4	$1.22M	Buy	7,001 +146	+2%	+$25.8K	0.04%	152
2017 Q3	$1.28M	Sell	6,855 -100	-1%	-$17.7K	0.04%	148
2017 Q2	$1.2M	Sell	6,955 -570	-8%	-$92.7K	0.04%	148
2017 Q1	$1.24M	Buy	7,525 +531	+8%	+$88.2K	0.04%	151
2016 Q4	$1.02M	Sell	6,994 -266	-4%	-$40K	0.04%	162
2016 Q3	$1.21M	Buy	7,260 +102	+1%	+$17.2K	0.04%	160
2016 Q2	$1.09M	Buy	7,158 +57	+0.8%	+$8.86K	0.04%	161
2016 Q1	$1.06M	Hold	7,101	–	–	0.04%	153
2015 Q4	$1.15M	Sell	7,101 -91	-1%	-$14.3K	0.05%	138
2015 Q3	$995K	Buy	7,192 +11	+0.2%	+$1.73K	0.04%	142
2015 Q2	$1.1M	Sell	7,181 -51	-0.7%	-$8.17K	0.04%	148
2015 Q1	$1.16M	Hold	7,232	–	–	0.04%	146
2014 Q4	$1.15M	Hold	7,232	–	–	0.04%	138
2014 Q3	$1.02M	Buy	7,232 +51	+0.7%	+$6.66K	0.04%	133
2014 Q2	$850K	Hold	7,181	–	–	0.03%	151
2014 Q1	$886K	Hold	7,181	–	–	0.03%	134
2013 Q4	$819K	Hold	7,181	–	–	0.03%	139
2013 Q3	$804K	Sell	7,181 -145	-2%	-$15.7K	0.03%	124
2013 Q2	$723K	Buy	+7,326	New	+$760K	0.03%	111

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Crawford Investment Counsel's AMGN Position: Q1 2026 in Review

Crawford Investment Counsel reduced its Amgen (AMGN) stake by 0.21% in Q1 2026, selling an estimated $5.7K and leaving 7,777 shares worth $2.74M. The position accounts for 0.05% of the portfolio, ranked #178.

Crawford Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Crawford Investment Counsel held 7,777 shares of Amgen worth $2.74M as of Q1 2026.
Crawford Investment Counsel sold 16 Amgen shares in Q1 2026, an estimated $5.7K.
Amgen made up 0.05% of Crawford Investment Counsel's portfolio in Q1 2026, its #178 holding.
Crawford Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Crawford Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.